We have ambitious future plans for the growth of our business as well as for the benefit..
Our Vision is to provide world class, cost-effective products for the international as well as domestic market reuirement..
We have constructed a modernized infrastructure unit to maintain smooth functioning of business activities.
Ever since our organization has been incepted, we have given utmost importance to the quality standards of the products.
Established in 1976, J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented, public listed organisation with a focus on supplying affordable, quality products both in India and International markets, JBCPL is trusted by healthcare professionals globally. Today, JBCPL exports to over 30 countries across the world and earns more than half its revenue from its international business.
JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules.
JBCPL has its headquarters in India’s financial capital, Mumbai. With a domestic sales force of 1,000 people, 17 internationally approved state of the art manufacturing units, a Research and Development Centre, and subsidiaries abroad, the organisation is continually enhancing value for its shareholders.
In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.
The Indian pharmaceutical market has been growing at an annual compounded rate of 15% and is valued at Rs. 55,000 crores ($10 billion). This surge can be attributed to higher private healthcare spending by Indians, greater penetration of pharmaceutical companies into the country’s interior, and an increasing awareness of chronic issues like cardiac disease and diabetes. According to a report by consultancy group McKinsey, pharmaceutical growth in India will triple to Rs. 1,00,000 crores (US$20 billion) by 2015 when India will be one of the world’s top 10 pharmaceutical markets.
JBCPL is among the top 40 pharmaceutical companies in the local market and the top 20 pharmaceutical companies with India and exports business.
JBCPL has three divisions
JBCPL has a presence in 22 major therapeutic groups with 108 brands in the domestic market. Some of JBCPL’s leading brands in India are in Amoebicides, Anti-peptic ulcerants, NSAID, Cardiac care, Quinolones and Antacids. They are among the top 300 brands in terms of units in the Indian pharmaceutical market
Some of these brands have achieved brand leadership in their segments
Below are brands that are top ranking in therapeutic segments:
In India we aim to:
1
2
3